Elleste Solo 1mg & 2mg
Last Updated on eMC 09-May-2016 View document | Meda Pharmaceuticals Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 09-May-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
Updated on 07-Oct-2015 and displayed until 09-May-2016
Reasons for adding or updating:
- Change to section 1 - what the product is
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 18-Sep-2014 and displayed until 07-Oct-2015
Reasons for adding or updating:
- Change to section 1 - what the product is
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - use in children/adolescents
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 2 - driving and using machines
- Change to section 2 - excipient warnings
- Change to section 3 - dose and frequency
- Change to section 3 - use in children/adolescents
- Change to section 3 - how to take/use
- Change to section 3 - duration of treatment
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 5 - how to store
- Change to section 6 - what the product contains
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Updated on 04-Dec-2009 and displayed until 18-Sep-2014
Reasons for adding or updating:
- Change due to harmonisation of PIL.
Updated on 21-Nov-2008 and displayed until 04-Dec-2009
Reasons for adding or updating:
- Change due to user-testing of patient information
Updated on 03-Nov-2008 and displayed until 21-Nov-2008
Reasons for adding or updating:
- Change to name of manufacturer
Updated on 08-Jul-2008 and displayed until 03-Nov-2008
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
- PIL Submitted in error
Meda Pharmaceuticals
Sky Way House, Parsonage Road, Takeley, Bishop's Stortford, CM22 6PU
0845 460 0002
+44 (0)1748 828 810
0845 460 0000
+44 (0)1748 828 810
+44 (0)1748 828 801
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue